SENIOR SCIENTIST & MPS/ NAMs STRATEGIST
CRISTIANAÂ TRINCONI
DMV, PhD
Bridging animal models and human-relevant platforms.
Clinical Expertise & Bio-Engineering
Results‑driven biomedical scientist and project manager with 15+ years advancing New Approach Methodologies (NAMs) and microphysiological systems (MPS). Expert in 3D bioprinted vascularized liver‑on‑chip, long‑term micropatterned hepatic models, and multi‑organ-on-a-chip platforms for DILI, NASH, and infectious diseases. Experienced in GMP/GLP‑aligned workflows, data‑driven drug discovery & ADMET studies. Cross‑functional leadership, driving human‑relevant, animal‑free drug development aligned with emerging FDA standards.
Professional Graphical Abstract
Technical Core
Organs-on-Chip (MPS)
3D bioprinted and micropatterned liver platforms for drug clearance and high-fidelity drug screening, ensuring long-term cell homeostasis.
Translational Toxicology
Drug Induced Liver Injury (DILI) and Nonalcoholic Steatohepatitis (NASH) bridging in vivo ground truth with human-relevant in vitro systems to advance predictive clinical outcomes.
Disease Modeling
Advanced engineered fabricated organ-on-chip platforms for specialized infectious disease studies (Leishmaniasis, HBV) enabling rapid and precise drug screening and mechanism of action (MOA) research.
ADME & DILI Assessment
Strategic assessment of DILI and ADME profiles utilizing human-relevant models to accelerate clinical translation safely.
Laboratory Scientist & LeadershipÂ
Driving high-impact biotech and pharma projects through cross-functional expertise and agile execution.
Agile Lab Leader
Cross-functional Bridge
NAMs Strategist
Project Consultant
Agile-certified and experienced scientist leading multi-disciplinary teams in human engineered tissues models development and validation for pre-clinical drug discovery and toxicological research.
Connects engineering, biomaterials, chemistry, biology, and clinical stakeholders to deliver qualification‑ready NAMs and MPS platforms, aligning scientific rigor with regulatory and business needs.
Guides biotech and pharma teams in adopting New Approach Methodology as organs-on-a-chip (MPS) and micropatterned tissues, from roadmap design and risk assessment to technology transfer and regulatory‑aligned validation.
Expert consultant for pharma-biotech scouting, leveraging DILI, ADME, and infectious diseases expertise to lead high-velocity scientific projects.
Reducing Animal Testing in Science
Committed to the 2026 FDA guidelines, I am dedicated to eliminating animal testing through advanced human-relevant models and New Approach Methodologies (NAMs).
Peer-reviewed articles
17
>890
Citations
Patent-pending in Engineered HUMAN Tissues and Microphysiological systems (NAMs)
2
Walter Colli Award
2×
Let's Work Together
Seeking strategic collaborations in NAMs. Let's explore how my expertise can streamline your next R&D project.
cristrinconi@gmail.com
Phone
Location
+1 312 619-7587
Broomfield- CO